TY - JOUR
T1 - MicroRNA Regulators of Anxiety and Metabolic Disorders
AU - Meydan, Chanan
AU - Shenhar-Tsarfaty, Shani
AU - Soreq, Hermona
N1 - Publisher Copyright:
© 2016 Elsevier Ltd
PY - 2016/9/1
Y1 - 2016/9/1
N2 - Anxiety-related and metabolic disorders are under intense research focus. Anxiety-induced microRNAs (miRNAs) are emerging as regulators that are not only capable of suppressing inflammation but can also induce metabolic syndrome-related processes. We summarize here evidence linking miRNA pathways which share regulatory networks in metabolic and anxiety-related conditions. In particular, miRNAs involved in these disorders include regulators of acetylcholine signaling in the nervous system and their accompanying molecular machinery. These have been associated with anxiety-prone states in individuals, while also acting as inflammatory suppressors. In peripheral tissues, altered miRNA pathways can lead to dysregulated metabolism. Common pathways in metabolic and anxiety-related phenomena might offer an opportunity to reclassify ‘healthy’ and ‘unhealthy’, as well as metabolic and anxiety-prone biological states, and inform putative strategies to treat these disorders.
AB - Anxiety-related and metabolic disorders are under intense research focus. Anxiety-induced microRNAs (miRNAs) are emerging as regulators that are not only capable of suppressing inflammation but can also induce metabolic syndrome-related processes. We summarize here evidence linking miRNA pathways which share regulatory networks in metabolic and anxiety-related conditions. In particular, miRNAs involved in these disorders include regulators of acetylcholine signaling in the nervous system and their accompanying molecular machinery. These have been associated with anxiety-prone states in individuals, while also acting as inflammatory suppressors. In peripheral tissues, altered miRNA pathways can lead to dysregulated metabolism. Common pathways in metabolic and anxiety-related phenomena might offer an opportunity to reclassify ‘healthy’ and ‘unhealthy’, as well as metabolic and anxiety-prone biological states, and inform putative strategies to treat these disorders.
KW - anxiety
KW - cholinergic
KW - metabolic disorder
KW - miRNAs
KW - obesity
UR - http://www.scopus.com/inward/record.url?scp=84990955534&partnerID=8YFLogxK
U2 - 10.1016/j.molmed.2016.07.001
DO - 10.1016/j.molmed.2016.07.001
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 27496210
AN - SCOPUS:84990955534
SN - 1471-4914
VL - 22
SP - 798
EP - 812
JO - Trends in Molecular Medicine
JF - Trends in Molecular Medicine
IS - 9
ER -